
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Gambling among youth is an underrecognized problem. To prevent serious consequences of this activity over the short term and during adulthood, the authors recommend that you screen patients for a gambling habit and refer those in whom you uncover cause for concern.






